Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
International Immunopharmacology|June 11, 2020
Comparative phenotypes of peripheral blood and spleen cells from cancer patientsKathryn E Cole, Quan P Ly, Michael A Hollingsworth, et al.
International Immunopharmacology|February 24, 2022
Splenic and PB immune recovery in neoadjuvant treated gastrointestinal cancer patientsKathryn E Cole, Quan P Ly, Michael A Hollingsworth, et al.
Cancers|October 26, 2024
MUC16 Retention after Neoadjuvant Chemotherapy in Pancreatic Ductal AdenocarcinomaKathryn M Muilenburg, Evie G Ehrhorn, Madeline T Olson, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 4, 2019
Phase I trial of concurrent stereotactic body radiotherapy and nelfinavir for locally advanced borderline or unresectable pancreatic adenocarcinomaChi Lin, Vivek Verma, Quan P Ly, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 27, 2020
CXCR2 signaling promotes secretory cancer-associated fibroblasts in pancreatic ductal adenocarcinomaMohammad Awaji, Sugandha Saxena, Lingyun Wu, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|January 13, 2018
Indocyanine green loaded hyaluronan-derived nanoparticles for fluorescence-enhanced surgical imaging of pancreatic cancerBowen Qi, Ayrianne J Crawford, Nicholas E Wojtynek, et al.
Molecular Pharmaceutics|May 31, 2022
Preclinical Evaluation of a Humanized, Near-Infrared Fluorescent Antibody for Fluorescence-Guided Surgery of MUC16-Expressing Pancreatic CancerMadeline T Olson, Eric N Aguilar, Cory L Brooks, et al.
American Journal of Clinical Oncology|September 13, 2019
Phase I/II Trial of Neoadjuvant Oregovomab-based Chemoimmunotherapy Followed by Stereotactic Body Radiotherapy and Nelfinavir For Locally Advanced Pancreatic AdenocarcinomaChi Lin, Vivek Verma, Audrey Lazenby, et al.
Cancers|September 11, 2019
Selective Inhibition of Histone Deacetylases 1/2/6 in Combination with Gemcitabine: A Promising Combination for Pancreatic Cancer TherapyRichard S Laschanzky, Lisa E Humphrey, Jihyun Ma, et al.
Diseases of the Colon and Rectum|May 21, 2010
Gene expression profiling of colorectal mucinous adenocarcinomasMarcovalerio Melis, Jonathan Hernandez, Erin M Siegel, et al.
Pageof 5